EU Medical Device CE Marking (MDR/IVDR)

EU Authorized Representative & Medical Device Registration

EU CE Marking and MDR / IVDR Compliance Guide for Medical Devices: This page covers the regulatory authorities, device classification, registration process, local representative requirements and FAQs for medical devices in the EU. Medical devices in the EU are regulated by the competent authorities of the Member States and by Notified Bodies, and EVERBIZ can support you through the entire process from classification to certification.

On This Page

  • What CE marking and the CE mark are

  • CE marking requirements and manufacturer obligations under the MDR

  • Key steps in medical device CE certification

  • IVDR: special requirements for in vitro diagnostic devices

  • Key transition periods and latest regulatory updates

  • EVERBIZ support services


1. What Are CE Certification and the CE Mark?

CE stands for the French Conformité Européenne (European Conformity). The CE mark indicates the manufacturer’s commitment that the product meets all applicable EU health, safety, performance and environmental requirements, and that it takes legal responsibility for this.

To sell a medical device or in vitro diagnostic device (IVD) in the European Union (EU), the product must bear the CE mark. The CE mark is also the passport to the European Economic Area (EEA) – the 27 EU Member States plus Iceland, Liechtenstein and Norway – and some non-EU countries such as Switzerland and Turkey also recognize it. The manufacturer bears ultimate responsibility for compliance, and this responsibility cannot be transferred even if some or all production is outsourced to third parties.

2. Core Obligations under the MDR

The legal basis for CE marking of medical devices is the EU Medical Device Regulation (MDR, Regulation (EU) 2017/745), fully applicable since 26 May 2021, which replaced the Medical Device Directive (MDD, 93/42/EEC) and the Active Implantable Medical Device Directive (AIMDD, 90/385/EEC).

The manufacturer’s main obligations include:

Obligation Description
General Safety and Performance Requirements (GSPR) Demonstrate that the device meets all applicable requirements of MDR Annex I
Technical documentation Prepared and continuously maintained in accordance with MDR Annexes II and III
Clinical evaluation CER prepared in accordance with MDR Annex XIV and MEDDEV 2.7/1 rev.4
Quality management system (QMS) Usually established on the basis of ISO 13485
Post-market surveillance (PMS) Ongoing activities including PSUR and PMCF
EUDAMED registration Data on economic operators, devices, UDI, etc.
Notified Body (NB) Required for all devices except Class I (non-sterile, without measuring function, not reusable surgical instruments)
EU Authorized Representative (EC REP) Mandatory for manufacturers located outside the EU
Declaration of Conformity (DoC) Self-declaration that the product complies with the MDR

3. Basic CE Certification Process

  1. Determine the product definition – confirm whether the product is a medical device under MDR Article 2.

  2. Determine the class – classify as Class I, IIa, IIb or III under MDR Annex VIII.

  3. Establish a QMS – in most cases based on ISO 13485.

  4. Prepare the technical documentation – including design, risk management, biological evaluation and clinical modules.

  5. Complete the clinical evaluation – gather evidence through literature, equivalence or clinical investigations.

  6. Appoint an EC REP (for manufacturers outside the EU).

  7. Notified Body assessment – review of the QMS and technical documentation (except self-declared Class I devices).

  8. EUDAMED registration – assign UDIs and register the device and economic operators.

  9. Sign the DoC and affix the CE mark – the product can then be placed on the EU market.


4. IVDR: A Separate Regulation for In Vitro Diagnostic Devices

In vitro diagnostic devices fall under the EU In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) 2017/746), applicable since 26 May 2022, which replaced the IVD Directive (IVDD, 98/79/EC). The IVDR has a framework similar to the MDR but with several key differences:

1. Different risk classification rules: The IVDR uses a rule-based classification system with four classes:

  • Class A – low risk (e.g. reagent-grade chemicals, general laboratory containers)

  • Class B – low-to-moderate risk (e.g. pregnancy self-tests, cholesterol tests)

  • Class C – moderate-to-high risk (e.g. tumor markers, staging diagnosis of infectious diseases)

  • Class D – high risk (e.g. HIV, HBV, HCV blood screening)

2. Much wider Notified Body involvement: Under the IVDD only about 8% of IVDs required Notified Body involvement; under the IVDR this rises to about 80% (all Class B, C and D devices and sterile Class A devices require NB review).

3. Stricter performance evaluation requirements: IVDR Annex XIII requires a three-part evaluation of scientific validity, analytical performance and clinical performance, documented in a Performance Evaluation Report (PER).

4. EU reference laboratories for high-risk products: Batches of Class D products must be verified by an EU Reference Laboratory (EURL).


5. Key Transition Periods and Latest Updates

MDR transition periods (under Regulation (EU) 2023/607)

Compliant devices meeting the conditions may remain on the market for longer, with deadlines depending on the risk class: 

Device class Latest deadline
Class III and Class IIb implantable (excluding sutures, dental fillings, etc.) 31 December 2027
Other Class IIb, Class IIa, Class I (sterile or measuring) 31 December 2028 
Class III custom-made implantable devices 26 May 2026

Conditions for the extension:

  • Application to an MDR Notified Body lodged before 26 May 2026, and a written agreement signed with the Notified Body before 26 September 2024 

  • A QMS compliant with MDR Article 10(9) is in place

  • No significant changes in the design or intended purpose of the device

IVDR transition periods (under Regulation (EU) 2024/1860)

Regulation (EU) 2024/1860, in force since 9 July 2024, further extended the IVDR transition periods:

IVD class Latest deadline
Class D 31 December 2027
Class C 31 December 2028
Class B, sterile Class A 31 December 2029

Other important changes (Regulation (EU) 2024/1860)

  • Module-by-module mandatory use of EUDAMED – instead of waiting for all six modules to be fully functional, use becomes mandatory module by module, with the first modules expected to become mandatory from January 2026. 

  • Obligation to notify supply interruptions – since 10 January 2025, manufacturers planning to interrupt or discontinue the supply of certain medical devices or IVDs must notify the competent authority in advance and, where necessary, their customers. 

  • “Sell-off” deadline removed – devices already lawfully placed on the market can continue to be made available without a common cut-off date.


6. EVERBIZ Support Services

Our European regulatory team can support you with:

  • Regulatory strategy and classification – MDR / IVDR applicability analysis and transition pathway planning

  • Technical documentation – structured according to MDR Annexes II and III or IVDR Annexes II and III

  • Clinical / performance evaluation – CER and PER writing and literature searches

  • Quality management system – ISO 13485 system setup and internal audits

  • Notified Body liaison – selection, application and responses to findings

  • EU Authorized Representative (EC REP) – with compliance offices in several European locations, we can act as your EC REP

  • EUDAMED registration and UDI assignment

  • Post-market compliance – ongoing PMS, PMCF and PSUR support

How EVERBIZ Can Help

EVERBIZ has offices in Shanghai, Hong Kong, Germany, Austria, Singapore, Malaysia, Thailand and Vietnam. Our Munich-based EVERBIZ GmbH can act as your EU Authorized Representative. For the EU market, we offer:

  • Product classification and registration pathway planning
  • Preparation and review of MDR/IVDR technical documentation, clinical evaluation reports and declarations of conformity
  • Local authorized representative / registration holder arrangements
  • Submission, responses to deficiency letters and progress tracking
  • Post-market compliance maintenance (changes, renewals, adverse event reporting)

Contact us for an EU medical device registration plan and quote, or see our registration services for other countries and regions.

EU Medical Device Registration FAQs

What is the legal basis for EU CE marking?

Medical devices are governed by the Medical Device Regulation (MDR, Regulation (EU) 2017/745), and in vitro diagnostic devices by the In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) 2017/746).

Must non-EU manufacturers appoint an EU Authorized Representative?

Yes. Under Article 11 of the MDR/IVDR, manufacturers located outside the EU must appoint an authorized representative established in the EU by means of a written mandate, and the authorized representative is jointly and severally liable for compliance.

Do all medical devices require Notified Body assessment?

No. Class I devices (other than sterile, measuring or reusable surgical instruments) can be self-declared by the manufacturer; Class Is/Im/Ir devices and Class IIa, IIb and III devices require Notified Body (NB) assessment.

Until when has the MDR transition period been extended?

Under Regulation (EU) 2023/607, provided the conditions are met, Class III and Class IIb implantable devices may benefit until 31 December 2027, and other Class IIb, Class IIa and Class I devices requiring a Notified Body until 31 December 2028.

Related Reading

Frequently asked questions

Does a Chinese or other non-EU manufacturer need an EU Authorised Representative?

Yes. Article 11 of the MDR and of the IVDR requires every manufacturer outside the EU to designate an EU Authorised Representative (EU REP) by written mandate; the EU REP's name and address must appear on the label. The EU REP keeps the technical documentation and Declaration of Conformity available, cooperates with competent authorities, verifies the EUDAMED registration and is jointly and severally liable with the manufacturer for defective devices. EVERBIZ GmbH (Munich, Germany) can act as your EU REP.

Which devices can be self-declared and which need a notified body?

MDR class I devices that are non-sterile, without measuring function and not reusable surgical instruments, and non-sterile IVDR class A devices, are self-declared by the manufacturer. Class Is, Im and Ir, classes IIa, IIb and III, and IVDR classes B, C and D require a notified body. Classification follows the rules in Annex VIII of the MDR and of the IVDR.

Is EUDAMED mandatory now, and what has to be registered?

Yes. Since 28 May 2026 the first four EUDAMED modules (actor registration, UDI/device registration, notified bodies and certificates, market surveillance) are mandatory. The manufacturer first registers as an actor and obtains an SRN (Single Registration Number), then registers the Basic UDI-DI and UDI-DI. For non-EU manufacturers the actor registration is first confirmed by the EU REP.

How long can legacy MDD/IVDD certificates still be used?

Under Regulation (EU) 2023/607, eligible MDD devices may remain on the market until 31 December 2027 (class III and class IIb implantables) or 31 December 2028 (other devices), provided an MDR-compliant QMS is in place and a written agreement with a notified body for MDR certification has been signed. For IVDs, Regulation (EU) 2024/1860 extends the transition to the end of 2027 (class D), 2028 (class C) and 2029 (class B and sterile class A).

What documents are needed for CE marking?

The core is the technical documentation under MDR Annexes II and III: device description and classification, labels and IFU, GSPR checklist, risk management, clinical evaluation, test reports (biocompatibility, electrical safety, sterilisation, etc.), post-market surveillance plan, plus a QMS according to ISO 13485. We can confirm the classification first and then give you a gap list.

Does it matter whether the EU REP is based in Germany, the Netherlands or another EU country?

Legally, no. The MDR and IVDR apply directly throughout the EU, so an EU REP established in any member state is valid in all of them – and in Iceland, Liechtenstein and Norway, which apply the EU device rules – and only one EU REP appears on the label. The real differences lie in the service: a qualified PRRC, communication in your language, fast cooperation with authorities and in EUDAMED, and adequate liability insurance.

Do I need a separate EU REP for each country I sell to?

No. One EU REP is designated per generic device group and covers the whole EU. Member states may, however, set the language of labels and IFU, so each country requires its official language version. Some countries also have national requirements for reimbursement or public procurement, but these do not depend on where your EU REP is located.

Does an EU REP need a PRRC (person responsible for regulatory compliance)?

Yes. Article 15(6) of the MDR and of the IVDR requires the EU REP to have permanently and continuously at its disposal at least one qualified PRRC. You can ask any EU REP for evidence of its PRRC's qualifications. EVERBIZ GmbH has a PRRC permanently based in Germany.

Can I change my EU REP, and how?

Yes. Article 12 of the MDR and of the IVDR requires an agreement between the manufacturer, the outgoing and the incoming EU REP covering the end date of the old mandate, the start date of the new one, the transition of labels and IFU, the transfer of documents and post-market surveillance. The link in EUDAMED must be updated as well. We support the complete switch.

What is a Free Sale Certificate (FSC) and who issues it in the EU?

A Free Sale Certificate (FSC) confirms that a device is legally placed on the market in the issuing country; many countries in the Middle East, Latin America and Southeast Asia require one for registration. Under Article 60 MDR the EU FSC is issued by the competent authority of the member state where the manufacturer or the EU REP has its registered place of business; it is valid for at most five years and never longer than the CE certificate. Non-EU manufacturers usually apply through their EU REP – EVERBIZ GmbH handles this for clients for whom we act as EU REP.

Does an FSC need notarisation or legalisation?

That depends on the destination country. If both countries are parties to the Hague Apostille Convention, an apostille is sufficient; otherwise legalisation by the destination country's embassy or consulate is usually required. China joined the Convention in November 2023. We can arrange notarisation and legalisation according to the destination country's requirements.

Scroll to Top